Guardant Health (GH) had a positive Q1, announced Medicare pricing and a contract with VA Hospital

From Yahoo Finance: 2025-04-22 10:48:00

Aristotle Atlantic Partners, LLC released its Q1 2025 investor letter, reporting a -5.90% return for its Core Equity Strategy, underperforming the S&P 500 Index. Guardant Health, Inc. was highlighted as a strong stock pick, with a one-month return of -4.39% and a market capitalization of $5.789 billion.

Guardant Health, Inc. (NASDAQ:GH) had a positive Q1, with announcements of Medicare pricing for its Guardant Shield test and a contract with the VA hospital system. Despite this, Guardant Health, Inc. (NASDAQ:GH) is not among the 30 Most Popular Stocks Among Hedge Funds, as AI stocks are seen as holding greater promise for higher returns.

Biotechnologists are seen in a laboratory testing an Immuno-oncology treatment. This shows the continued focus and innovation within the biotechnology sector.

Read more: Guardant Health (GH) Rose Following Several Positive News Reports